Woodline Partners LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$6.5B
Holdings
792
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (792 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 201 | NKENIKE INC | 77,645 | $7.9B | 122.28% | |
| 202 | —L CATTERTON ASIA ACQUISITION | 800,000 | $7.8B | 120.81% | |
| 203 | OKLOALTC ACQUISITION CORP | 800,000 | $7.7B | 118.96% | |
| 204 | —FINTECH ACQUISITION CORP VI | 776,019 | $7.6B | 117.67% | |
| 205 | BIIBBIOGEN INC | 37,412 | $7.6B | 117.58% | |
| 206 | ELLAUDER ESTEE COS INC | 29,781 | $7.6B | 116.87% | |
| 207 | AMLXAMYLYX PHARMACEUTICALS INC | 390,229 | $7.5B | 115.82% | |
| 208 | DGXQUEST DIAGNOSTICS INC | 55,833 | $7.4B | 114.42% | |
| 209 | —CARTESIAN GROWTH CORP | 749,999 | $7.4B | 113.60% | |
| 210 | PDCOEURPATTERSON COS INC | 243,050 | $7.4B | 113.48% | |
| 211 | —RESEARCH ALLIANCE CORP II | 750,000 | $7.3B | 112.92% | |
| 212 | —AUSTERLITZ ACQUISITION CORP | 750,000 | $7.3B | 112.69% | |
| 213 | ITCIEURINTRA-CELLULAR THERAPIES INC | 127,342 | $7.3B | 112.01% | |
| 214 | DISHDISH NETWORK CORPORATION | 396,421 | $7.1B | 109.53% | |
| 215 | 290ACHINOOK THERAPEUTICS INC | 401,023 | $7.0B | 108.08% | |
| 216 | XENEXENON PHARMACEUTICALS INC | 228,928 | $7.0B | 107.31% | |
| 217 | —AFFIMED N V | 2,510,083 | $7.0B | 107.14% | |
| 218 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 255,533 | $6.8B | 104.11% | |
| 219 | PMVPPMV PHARMACEUTICALS INC | 469,883 | $6.7B | 103.18% | |
| 220 | SUXTD SYNNEX CORPORATION | 73,401 | $6.7B | 103.04% | |
| 221 | DDOGDATADOG INC | 68,689 | $6.5B | 100.81% | |
| 222 | ALTALTIMMUNE INC | 550,685 | $6.4B | 99.28% | |
| 223 | CNTACENTESSA PHARMACEUTICALS PLC | 1,314,652 | $6.4B | 98.65% | |
| 224 | XRAYDENTSPLY SIRONA INC | 179,001 | $6.4B | 98.56% | |
| 225 | VRDNVIRIDIAN THERAPEUTICS INC | 552,371 | $6.4B | 98.48% | |
| 226 | LUNGPULMONX CORP | 431,632 | $6.4B | 97.91% | |
| 227 | CASYCASEYS GEN STORES INC | 33,791 | $6.3B | 96.33% | |
| 228 | TJXTJX COS INC NEW | 110,901 | $6.2B | 95.45% | |
| 229 | EMREMERSON ELEC CO | 77,360 | $6.2B | 94.82% | |
| 230 | EWTXEDGEWISE THERAPEUTICS INC | 771,797 | $6.1B | 94.68% | |
| 231 | SF9SANDERSON FARMS INC | 28,499 | $6.1B | 94.65% | |
| 232 | PKNPERKINELMER INC | 42,400 | $6.0B | 92.92% | |
| 233 | FRPTFRESHPET INC | 116,181 | $6.0B | 92.91% | |
| 234 | CHECLATAMGROWTH SPAC | 600,000 | $6.0B | 92.09% | |
| 235 | —DUDDELL STREET ACQUISITN COR | 600,000 | $6.0B | 91.72% | |
| 236 | —HENNESSY CAPITAL INVS CORP V | 600,002 | $5.9B | 90.79% | |
| 237 | —AGILE GROWTH CORP | 599,999 | $5.9B | 90.79% | |
| 238 | MDGLMADRIGAL PHARMACEUTICALS INC | 82,176 | $5.9B | 90.64% | |
| 239 | 2L9BLUEPRINT MEDICINES CORP | 116,087 | $5.9B | 90.36% | |
| 240 | APPNAPPIAN CORP | 123,724 | $5.9B | 90.30% | |
| 241 | —DRAGONEER GROWTH OPT CORP II | 600,000 | $5.8B | 89.96% | |
| 242 | PYPLPAYPAL HLDGS INC | 82,270 | $5.7B | 88.54% | |
| 243 | —EPIZYME INC | 3,866,148 | $5.7B | 87.57% | |
| 244 | 3M4MASIMO CORP | 43,036 | $5.6B | 86.66% | |
| 245 | RLAYRELAY THERAPEUTICS INC | 331,663 | $5.6B | 85.60% | |
| 246 | VORVOR BIOPHARMA INC | 1,111,123 | $5.5B | 85.09% | |
| 247 | IOVAIOVANCE BIOTHERAPEUTICS INC | 499,770 | $5.5B | 85.02% | |
| 248 | XPOFXPONENTIAL FITNESS INC | 435,426 | $5.5B | 84.28% | |
| 249 | ROSTROSS STORES INC | 76,631 | $5.4B | 82.94% | |
| 250 | ESPRESPERION THERAPEUTICS INC NE | 844,635 | $5.4B | 82.78% | |
| 251 | DNLIDENALI THERAPEUTICS INC | 180,972 | $5.3B | 82.07% | |
| 252 | —BLUESCAPE OPPORTUNITIES ACQU | 537,001 | $5.3B | 82.01% | |
| 253 | CELHCELSIUS HLDGS INC | 81,494 | $5.3B | 81.95% | |
| 254 | SPLKCHFSPLUNK INC | 59,479 | $5.3B | 81.09% | |
| 255 | FISFIDELITY NATL INFORMATION SV | 57,153 | $5.2B | 80.73% | |
| 256 | RVMDREVOLUTION MEDICINES INC | 263,799 | $5.1B | 79.22% | |
| 257 | NVCRNOVOCURE LTD | 73,925 | $5.1B | 79.18% | |
| 258 | PCRXPACIRA BIOSCIENCES INC | 87,832 | $5.1B | 78.91% | |
| 259 | ZNTLZENTALIS PHARMACEUTICALS INC | 181,272 | $5.1B | 78.50% | |
| 260 | —BCLS ACQUISITION CORP | 512,616 | $5.1B | 78.20% | |
| 261 | —LAZARD GROWTH ACQUISITION CO | 512,450 | $5.0B | 77.39% | |
| 262 | —INDUSTRIAL HUMAN CAPITAL INC | 489,779 | $4.9B | 75.69% | |
| 263 | KURAKURA ONCOLOGY INC | 267,683 | $4.9B | 75.62% | |
| 264 | —FOREST ROAD ACQUISITION COR | 500,000 | $4.9B | 75.48% | |
| 265 | CCIXCHURCHILL CAPITAL CORP VII | 500,000 | $4.9B | 75.28% | |
| 266 | —REVOLUTION HEALTHCAR AQ CORP | 500,000 | $4.9B | 75.20% | |
| 267 | —ACCELERATE ACQUISITION CORP | 500,000 | $4.9B | 75.20% | |
| 268 | SGFYGBPSIGNIFY HEALTH INC | 351,786 | $4.9B | 74.81% | |
| 269 | ISIIONIS PHARMACEUTICALS INC | 129,908 | $4.8B | 74.11% | |
| 270 | —ANZU SPECIAL ACQUISITIN CORP | 475,000 | $4.7B | 71.66% | |
| 271 | DYNDYNE THERAPEUTICS INC | 666,997 | $4.6B | 70.61% | |
| 272 | AEAEALTENERGY ACQUISITION CORP | 450,000 | $4.5B | 68.87% | |
| 273 | —ATLAS CREST INVESTMENT CORP | 455,000 | $4.5B | 68.79% | |
| 274 | —CONX CORP | 450,000 | $4.4B | 68.54% | |
| 275 | BRBRBELLRING BRANDS INC | 178,637 | $4.4B | 68.51% | |
| 276 | —SVF INVESTMENT CORP | 449,847 | $4.4B | 68.34% | |
| 277 | WOOFPETCO HEALTH & WELLNESS CO I | 300,636 | $4.4B | 68.28% | |
| 278 | —PERIDOT ACQUISITION CORP II | 450,000 | $4.4B | 68.03% | |
| 279 | —BOA ACQUISITION CORP | 450,000 | $4.4B | 67.90% | |
| 280 | —TCW SPECIAL PURPOSE ACQU COR | 449,999 | $4.4B | 67.60% | |
| 281 | —OSIRIS ACQUISITION CORP | 450,000 | $4.4B | 67.54% | |
| 282 | —MASON INDUSTRIAL TECHNOLGY I | 445,000 | $4.4B | 67.06% | |
| 283 | —COMPUTE HEALTH ACQUISITIN CO | 443,553 | $4.4B | 67.05% | |
| 284 | LECOLINCOLN ELEC HLDGS INC | 35,122 | $4.3B | 66.77% | |
| 285 | —ALLOVIR INC | 1,087,093 | $4.2B | 65.34% | |
| 286 | ADSKAUTODESK INC | 24,641 | $4.2B | 65.29% | |
| 287 | PASGPASSAGE BIO INC | 1,788,059 | $4.2B | 65.03% | |
| 288 | BBYBEST BUY INC | 61,977 | $4.0B | 62.26% | |
| 289 | —HEALTH SCIENCES ACQ CORP 2 | 403,699 | $4.0B | 61.96% | |
| 290 | —OCA ACQUISITION CORP | 397,736 | $4.0B | 61.41% | |
| 291 | FATEFATE THERAPEUTICS INC | 160,718 | $4.0B | 61.38% | |
| 292 | —OPY ACQUISITION CORP I | 400,000 | $3.9B | 60.84% | |
| 293 | —FTAC ATHENA ACQUISITION CORP | 399,975 | $3.9B | 60.50% | |
| 294 | —HUDSON EXECUTIVE INVES III | 400,000 | $3.9B | 60.44% | |
| 295 | —DIGITAL TRANSFORMATN OPT COR | 400,000 | $3.9B | 60.28% | |
| 296 | IGTINTERNATIONAL GAME TECHNOLOG | 210,783 | $3.9B | 60.28% | |
| 297 | —AUSTERLITZ ACQUISITION CORP | 400,000 | $3.9B | 60.10% | |
| 298 | —ARYA SCIENCES ACQUISITN CORP | 400,000 | $3.9B | 59.91% | |
| 299 | AVDLAVADEL PHARMACEUTICALS PLC | 1,585,292 | $3.9B | 59.60% | |
| 300 | —COLONNADE ACQUISITION CORP I | 386,122 | $3.8B | 58.25% |